Answers are grounded in this paper and cite their sources.
Human trials on the globo H carbohydrate vaccine (see picture, KLH=the carrier protein keyhole limpet hemocyanin) show that it produces strong IgM, and in some cases IgG, responses in patients with progressive and recurrent prostate cancer. Furthermore, these antibodies not only recognize synthetic antigens, but also globo H-positive tumors in biopsy extracts and tumor tissues.
No takes yet. Share an insight, caveat, or question.
Ragupathi et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: